| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Mbx Biosciences IncMBX | +388.13% | $12.43 | $60.68 | 2025-07-16 - 2026-07-15 | Buy |
Mbx Biosciences IncMBX | +217.19% | $18.96 | $60.14 | 2025-09-23 - 2026-07-20 | Buy |
Palvella Therapeutics IncPVLA | +118.92% | $56.71 | $124.15 | 2025-09-09 - 2026-07-20 | Buy |
Ligand Pharmaceuticals IncLGND | +117.40% | $135.23 | $293.99 | 2025-07-30 - 2026-07-20 | Buy |
Ligand Pharmaceuticals IncLGND | +111.92% | $104.48 | $221.41 | 2025-05-09 - 2026-05-08 | Buy |
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ligand Pharmaceuticals IncLGND | 8 | Buy | $277.00 | -5.78% | Maintains | 5 months ago |
Bridgebio Pharma IncBBIO | 2 | Buy | $81.00 | +0.30% | Maintains | 5 months ago |
Legend Biotech CorpLEGN | 1 | Buy | $75.00 | +223.14% | Initiates Coverage On | 6 months ago |
Design Therapeutics IncDSGN | 1 | Buy | $18.00 | +51.64% | Initiates Coverage On | 6 months ago |
Theravance Biopharma IncTBPH | 1 | Buy | $27.00 | +60.62% | Initiates Coverage On | 8 months ago |
Mbx Biosciences IncMBX | 2 | Buy | $80.00 | +33.02% | Maintains | 10 months ago |
Palvella Therapeutics IncPVLA | 1 | Buy | $85.00 | -31.53% | Initiates Coverage On | 10 months ago |
Innoviva IncINVA | 1 | Buy | $35.00 | +64.47% | Initiates Coverage On | a year ago |